Hematologic changes in a patient with heparin-induced thrombocytopenia who underwent cardiopulmonary bypass after ancrod defibrinogenation

J Cardiothorac Vasc Anesth. 1996 Dec;10(7):918-21. doi: 10.1016/s1053-0770(96)80057-7.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Ancrod / therapeutic use*
  • Anticoagulants / adverse effects*
  • Cardiopulmonary Bypass*
  • Female
  • Fibrinolytic Agents / therapeutic use*
  • Heparin / adverse effects*
  • Humans
  • Thrombocytopenia / chemically induced*
  • Tissue Plasminogen Activator / metabolism

Substances

  • Anticoagulants
  • Fibrinolytic Agents
  • Heparin
  • Ancrod
  • Tissue Plasminogen Activator